AsuraGen, a US-based diagnostic development company and genomic services provider, has raised $5m of a planned $10m round from a consortium apparently including local drugs maker Merck, accoridng to a regulatory filing.

Humedica, a US-based clinical intelligence company for health care providers, life sciences and research organizations, has raised $33m in its series C round from a consortium including local drugs maker Merck.

Ambit, formerly known as Aventa Biosciences, has hired investment banks Citigroup and Leerink Swann for its $57.5m initial public offering (IPO) after raising more than $165m.

In July, Rex Health Ventures, a $10m fund managed on behalf of the eponymous community non-profit hospital, invested $500,000 in Aerial.

Globes said other Israeli life sciences companies were also planning their US initial public offering, including Kamada, Alcobra and Home Skinovations.

Founded in 2010, Avraham said it had now raised $14.7m to test patients with Alzheimer's disease after a $9m round in April 2010.

Founded in 2010, Avraham said it had now raised $14.7m to to test patients with Alzheimer's disease after a $9m round in April 2010.

In December, SynapDx raised $6m in its series B round from venture capital firms North Bridge Venture Partners and General Catalyst Partners.

Swiss Federal Institute of Technology (ETH) Zurich spin-out Qvanteq raises CHF 4m ($4.3m).